On November 18, Molina Healthcare fell 4.15% in Regular Trading, trading at $223.22 per share, with turnover of $105 million.
The move aligned with weakness across managed care after US regulators issued a proposed rule aimed at reducing fraud, waste, and abuse across Medicare, Medicaid, and marketplace plans.
The proposal is expected to save taxpayers nearly $90 billion over 10 years and includes more frequent Medicare Advantage audits, stronger enrollment safeguards, and tighter review of deductions from Medicaid payments. The broader sector also weakened, with UnitedHealth falling 5.76%, Humana falling 4.77%, Elevance Health falling 2.89%, and Centene falling 3.0%. Molina Healthcare had risen previously on a temporary easing of Medicaid work-rule enforcement, but the latest regulatory overhang overtook that earlier policy relief.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments